Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy
- PMID: 12487806
- DOI: 10.1089/088922202320935429
Immune activation in patients infected with HIV type 1 and maintaining suppression of viral replication by highly active antiretroviral therapy
Abstract
Immune activation associated with HIV infection declines after highly active antiretroviral therapy (HAART), but may persist or recur in some patients. It is not clear whether this reflects a resurgence of HIV replication or another cause of immune activation, such as inflammatory reactions to opportunistic pathogens (immune restoration disease [IRD]). Here, we studied plasma and cellular immune activation markers in adult HIV-1 patients who had received HAART for >12 months and maintained plasma HIV RNA levels of <400 copies/ml for >6 months. Plasma interleukin 1 receptor antagonist and tumor necrosis factor receptor I levels were similar in patients and HIV-negative control subjects, but the highest levels occurred mainly in patients with a history of IRD. In contrast, expression of HLA-DR and CD38 on monocytes and of HLA-DR on CD8(+) T cells was higher in patients than in control subjects. Thus, cellular markers of immune activation are abnormal in some patients with a good virological response to HAART, and abnormalities of plasma immune activation markers correlate with a history of IRD.
Similar articles
-
CD38 expression on CD8 T lymphocytes as a marker of residual virus replication in chronically HIV-infected patients receiving antiretroviral therapy.AIDS Res Hum Retroviruses. 2004 Feb;20(2):227-33. doi: 10.1089/088922204773004950. AIDS Res Hum Retroviruses. 2004. PMID: 15018711
-
Residual viraemia in HIV-1-infected patients with plasma viral load <or=20 copies/ml is associated with increased blood levels of soluble immune activation markers.Scand J Immunol. 2008 Dec;68(6):652-60. doi: 10.1111/j.1365-3083.2008.02184.x. Scand J Immunol. 2008. PMID: 19055701
-
Cd38 expression on Cd8+ T cells in Human immunodeficiency virus 1-positive adults treated with HAART.Acta Virol. 2003;47(2):121-4. Acta Virol. 2003. PMID: 14524479
-
Immune restoration disease in HIV patients: aberrant immune responses after antiretroviral therapy.J HIV Ther. 2002 May;7(2):46-51. J HIV Ther. 2002. PMID: 12553688 Review.
-
Immune restoration disease: a consequence of dysregulated immune responses after HAART.Curr HIV Res. 2004 Jul;2(3):235-42. doi: 10.2174/1570162043351345. Curr HIV Res. 2004. PMID: 15279587 Review.
Cited by
-
HIV patients stable on ART retain evidence of a high CMV load but changes to Natural Killer cell phenotypes reflect both HIV and CMV.AIDS Res Ther. 2015 Dec 9;12:41. doi: 10.1186/s12981-015-0080-9. eCollection 2015. AIDS Res Ther. 2015. PMID: 26664457 Free PMC article.
-
Dysfunctional HDL and progression of atherosclerosis in HIV-1-infected and -uninfected adults.Lipids Health Dis. 2013 Mar 5;12:23. doi: 10.1186/1476-511X-12-23. Lipids Health Dis. 2013. PMID: 23510548 Free PMC article.
-
The forces driving clonal expansion of the HIV-1 latent reservoir.Virol J. 2020 Jan 7;17(1):4. doi: 10.1186/s12985-019-1276-8. Virol J. 2020. PMID: 31910871 Free PMC article. Review.
-
Mechanistic insights on immunosenescence and chronic immune activation in HIV-tuberculosis co-infection.World J Virol. 2015 Feb 12;4(1):17-24. doi: 10.5501/wjv.v4.i1.17. World J Virol. 2015. PMID: 25674514 Free PMC article. Review.
-
HIV-Exposed Uninfected Infants in Zimbabwe: Insights into Health Outcomes in the Pre-Antiretroviral Therapy Era.Front Immunol. 2016 Jun 6;7:190. doi: 10.3389/fimmu.2016.00190. eCollection 2016. Front Immunol. 2016. PMID: 27375613 Free PMC article.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
